Showing results (11-20 of 68) with videos related to
Sort By:
Pageof 7
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 24, 2009
Targeted therapy for endocrine cancer: the medullary thyroid carcinoma paradigmLei Ye, Libero Santarpia, Robert F GagelInternational Journal of Endocrinology|March 20, 2013
Cellular signaling pathway alterations and potential targeted therapies for medullary thyroid carcinomaSerena Giunti, Alessandro Antonelli, Andrea Amorosi, et al.Expert Opinion on Biological Therapy|March 24, 2017
Progress in nonviral gene therapy for breast cancer and what comes next?Giulia Bottai, Marta Truffi, Fabio Corsi, et al.Thyroid : Official Journal of the American Thyroid Association|March 31, 2006
Human thyroid autoantigens and proteins of Yersinia and Borrelia share amino acid sequence homology that includes binding motifs to HLA-DR molecules and T-cell receptorSalvatore Benvenga, Libero Santarpia, Francesco Trimarchi, et al.Expert Opinion on Biological Therapy|September 6, 2014
Targeting the microRNA-regulating DNA damage/repair pathways in cancerGiulia Bottai, Barbara Pasculli, George A Calin, et al.Future Oncology (London, England)|February 25, 2011
Fulvestrant in the management of postmenopausal women with advanced, endocrine-responsive breast cancerCatherine Oakman, Erica Moretti, Libero Santarpia, et al.Expert Opinion on Therapeutic Targets|January 14, 2012
Targeting the MAPK-RAS-RAF signaling pathway in cancer therapyLibero Santarpia, Scott M Lippman, Adel K El-NaggarThyroid : Official Journal of the American Thyroid Association|January 27, 2005
Homologies between proteins of Borrelia burgdorferi and thyroid autoantigensSalvatore Benvenga, Fabrizio Guarneri, Mario Vaccaro, et al.Cancer Treatment Reviews|September 18, 2009
The role of topoisomerase IIalpha and HER-2 in predicting sensitivity to anthracyclines in breast cancer patientsCatherine Oakman, Erica Moretti, Francesca Galardi, et al.Journal of Experimental & Clinical Cancer Research : CR|June 29, 2016
Targeting microRNAs as key modulators of tumor immune responseLaura Paladini, Linda Fabris, Giulia Bottai, et al.Pageof 7